CoLucid Pharmaceuticals, Inc. Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 4 of 4 Posts
Trump Twitter Hangover Keeps Biotech Stocks Down
Article By: Rod Raynovich Thursday, January 19, 2017 1:30 AM EDT
Biotech stocks were getting traction until Day 3 of the J.P.Morgan Healthcare Conference when Trump tweeted out his attack on drug prices suggesting Medicare negotiate for a better deal on drug prices.
In this article: LLY, IBB, SGEN, BIIB, VRTX, XBI, RDUS, CLCD
Read
4 Biotech Stocks That More Than Doubled In 2016
Article By: Arpita Dutt Thursday, December 22, 2016 11:47 AM EDT
2016 has not been a great year for biotech stocks, which were under intense pressure with issues like increasing political and media focus on high price tags for drugs, and the changing competitive scenario weighing on the sector.
In this article: CLCD, EXEL, TSRO, AKAO
Read
Why After A Massive Run, CoLucid Shares Still Look Attractive
Article By: Jason Napodano Monday, October 31, 2016 9:02 AM EDT
CoLucid Pharmaceuticals shares are up ~290% YTD, and I think that's just the beginning.
In this article: CLCD Also: AGN, LLY, MRK, AMGN, TEVA, ALDR, XBI
Read
CoLucid Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire Friday, September 9, 2016 5:45 PM EDT
CoLucid Pharmaceuticals, Inc. today announced the pricing of an underwritten public offering of 3,250,000 shares of its common stock at a public offering price of $20.00 per share, for aggregate gross proceeds of $65.0 million.
In this article: CLCD
Read
1 to 4 of 4 Posts